Àá½Ã¸¸ ±â´Ù·Á ÁÖ¼¼¿ä. ·ÎµùÁßÀÔ´Ï´Ù.
KMID : 1191520110160010033
Journal of Korean Traditional Oncology
2011 Volume.16 No. 1 p.33 ~ p.39
Case Report of the Pancreatic Cancer Patient after Pancreatoduodenectomy who is Taking the HangAm-Plus to Anti-metastasis and Preventing Recurrence
Kim Jong-Min

Park Jae-Woo
Yoo Hwa-Seung
Lee Yeon-Weol
Cho Chong-Kwan
Abstract
Objective :To investigate the anti-metastasis and preventing relapses of HangAm-Plus (HAP) on pancreatic cancer patient.

Methods: A 49 year old male patient diagnosed with pancreatic cancer (T3N0M0) was admitted to EWCC (East-West Cancer Center) on Jul. 21st 2008. He had operated pylorus preserving pancreatoduodenectomy (PPPD) and came to the anti-metastasis and preventing relapses on pancreatic cancer patient. The patient was treated with HangAm-Plus (HAP) (3,000 mg/day) for the period of 33 months from Jul. 21st, 2008 to Apr. 7th, 2011. Tumor markers (CEA and CA19-9) were used to evaluate the disease progression of the patient. Positron Emission Tomography (PET) and Computed Tomography (CT) were also followed up.

Results:HAP treatment was well tolerated by the patient. Patient has shown 33 months of disease free survival until now.

Conclusion: This case study supports HAP¡¯s potential efficacy in the anti-metastasis and preventing relapses of pancreatic cancer patient.
KEYWORD
HangAm-Plus, Pancreatic Cancer, Disease Free Survival
FullTexts / Linksout information
 
Listed journal information